Urogenital dysfunction in myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease

被引：0
|
作者：
Li, V. [1 ,2 ]
Da Silva Leite, M. [3 ]
Messina, S. [3 ]
Everett, R. [3 ]
Panicker, J. [2 ]
Palace, J. [3 ]
机构：
[1] UCL, UCL Inst Neurol, Queen Sq Multiple Sclerosis Ctr, London, England
[2] Natl Hosp Neurol & Neurosurg, Dept Uroneurol, London, England
[3] Oxford Univ Hosp NHS Fdn Trust, Nuffield Dept Clin Neurosci, Oxford, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P372
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [41] Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Presentation and Outcomes
    Sutton, P. E.
    Shah, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 146 - 147
  • [42] Phenotype of Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in Children
    Han, Ji Yeon
    Kim, Soo Yeon
    Kim, Woojoong
    Kim, Hunmin
    Cho, Anna
    Choi, Jieun
    Chae, Jong-Hee
    Kim, Ki Joong
    Kwon, Young Se
    Yoo, Il Han
    Lim, Byung Chan
    JOURNAL OF CLINICAL NEUROLOGY, 2025, 21 (01): : 65 - 73
  • [43] Corpus Callosum Involvement in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
    Chia, N. H.
    Chen, J. J.
    Pittock, S. J.
    Flanagan, E. P.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 144 - 144
  • [44] ElasomeranMyelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD): case report
    Reactions Weekly, 2022, 1903 (1) : 169 - 169
  • [45] Correction to: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
    M. D. Willis
    N. P. Robertson
    Journal of Neurology, 2018, 265 : 2469 - 2469
  • [46] Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease and MOG Testing Landscape in Canada
    Burton, Jodie
    Youn, Saerom
    Al-Ani, Abdullah
    Costello, Fiona
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 409 - 410
  • [47] Clinical spectrum, treatment and outcome of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease in children: a tertiary care experience
    Hepsen Mine Serin
    Sanem Yilmaz
    Erdem Simsek
    Seda Kanmaz
    Cenk Eraslan
    Gul Aktan
    Hasan Tekgul
    Sarenur Gokben
    Acta Neurologica Belgica, 2021, 121 : 231 - 239
  • [48] Clinical spectrum, treatment and outcome of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease in children: a tertiary care experience
    Serin, Hepsen Mine
    Yilmaz, Sanem
    Simsek, Erdem
    Kanmaz, Seda
    Eraslan, Cenk
    Aktan, Gul
    Tekgul, Hasan
    Gokben, Sarenur
    ACTA NEUROLOGICA BELGICA, 2021, 121 (01) : 231 - 239
  • [49] Clinical, MRI and laboratory features of myelin oligodendrocyte glycoprotein (MOG)-antibody-associated neurologic disease: a study of 259 cases
    Kaneko, K.
    Sato, D. K.
    Takahashi, T.
    Ogawa, R.
    Akaishi, T.
    Takai, Y.
    Nishiyama, S.
    Misu, T.
    Kuroda, H.
    Nakashima, I.
    Fujihara, K.
    Aoki, M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 100 - 100
  • [50] Microcystic macula edema in myelin oligodendrocyte glycoprotein (MOG-) antibody-associated relapsing optic neuritis
    Havla, J.
    Outteryck, O.
    Schmidt, F.
    Spadaro, M.
    Meinl, E.
    Hohlfeld, R.
    Kuempfel, T.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 215 - 216
12345